Acceptability of the oral hormonal male contraceptive prototype, 11β-methyl-19-nortestosterone dodecylcarbonate (11β-MNTDC), in a 28-day placebo-controlled trial
Brian T. Nguyen, Fiona Yuen, Maritza T. Farrant, Arthi Thirumalai, Frances Fernando, John K. Amory, Ronald S. Swerdloff, Bradley D. Anawalt, Diana Blithe, Jill Long, Peter Y. Liu, Stephanie T. Page, Christina Wang
Topics & Concepts
MedicinePillPlaceboRegimenFamily planningClinical trialOral contraceptive pillRandomized controlled trialPatient satisfactionHormonal contraceptionGynecologyInternal medicinePopulationAlternative medicineSurgeryPharmacologyResearch methodologyPathologyEnvironmental healthHormonal and reproductive studiesEstrogen and related hormone effectsPharmacogenetics and Drug Metabolism